Strategies targeting cAMP signaling in the treatment of polycystic kidney disease

VE Torres, PC Harris - Journal of the American Society of …, 2014 - journals.lww.com
Polycystic kidney disease (PKD) is a leading cause of ESRD worldwide. In PKD, excessive
cell proliferation and fluid secretion, pathogenic interactions of mutated epithelial cells with …

Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation

MF Horster, GS Braun, SM Huber - Physiological reviews, 1999 - journals.physiology.org
Embryonic metanephroi, differentiating into the adult kidney, have come to be a generally
accepted model system for organogenesis. Nephrogenesis implies a highly controlled …

[HTML][HTML] Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins

Y Huan, J van Adelsberg - The Journal of clinical …, 1999 - Am Soc Clin Investig
Autosomal dominant polycystic kidney disease (ADPKD) is a common human genetic
disease characterized by cyst formation in kidney tubules and other ductular epithelia. Cells …

Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease

Y Zhang, G Reif, DP Wallace - Cellular signalling, 2020 - Elsevier
In autosomal dominant polycystic kidney disease (ADPKD), the inexorable growth of
numerous fluid-filled cysts leads to massively enlarged kidneys, renal interstitial damage …

Integrins in kidney development, function, and disease

JA Kreidberg, JM Symons - American Journal of Physiology …, 2000 - journals.physiology.org
Integrins are heterodimeric cell surface receptors that mediate heterophilic cell-cell
interactions and interactions between cells and the extracellular matrix (Hynes RO. Cell 69 …

The genetics and physiology of polycystic kidney disease

JP Calvet, JJ Grantham - Seminars in nephrology, 2001 - seminarsinnephrology.org
Autosomal dominant polycystic kidney disease (ADPKD) is a major, inherited disorder that is
characterized by the growth of large, fluid-filled cysts from the tubules and collecting ducts of …

[HTML][HTML] Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling

X Zhou, VE Torres - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Autosomal dominant polycystic kidney disease (ADPKD), with an estimated genetic
prevalence between 1: 400 and 1: 1,000 individuals, is the third most common cause of end …

Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1

K Lee, S Boctor, LMC Barisoni… - Journal of the American …, 2015 - journals.lww.com
Abstract Dysregulation of polycystin-1 (PC1) leads to autosomal dominant polycystic kidney
disease (ADPKD), a disorder characterized by the formation of multiple bilateral renal cysts …

Dysplastic and polycystic kidneys: diagnosis, associations and management

P Winyard, L Chitty - … Diagnosis: Published in Affiliation With the …, 2001 - Wiley Online Library
Cystic and bright kidneys can pose a significant diagnostic dilemma when discovered as an
incidental finding at the time of a routine fetal ultrasound scan. There are diverse aetiologies …

Mouse models of polycystic kidney disease

PD Wilson - Current topics in developmental biology, 2008 - Elsevier
Polycystic kidney disease (PKD) is a diverse group of human monogenic lethal conditions
inherited as autosomal dominant (AD) or recessive (AR) traits. Recent development of …